2 Minute Medicine Rewind November 24, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age 1. Incidence rates...
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age 1. Incidence rates...
Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial 1. Vernakalant was superior...
Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial 1. In this randomized clinical trial, combination...
Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with...
Development of a Clinical Prediction Model for Anastomotic Leakage in Colorectal Surgery 1. An integrative machine learning predictive model based...
Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes 1. In patients with type 2 diabetes (T2D),...
Rate of incident dementia and care needs among older adults with new traumatic brain injury: a population-based cohort study 1....
Glycaemic control and influencing factors among patients with post-chronic pancreatitis diabetes mellitus in China: a retrospective cross-sectional study 1. Smoking...
Factors in the Initial Resuscitation of Patients With Severe Trauma: The FiiRST-2 Randomized Clinical Trial 1. Replacing clotting factors with...
Lactate-to-albumin ratio and 28 day mortality in hypertensive patients with atrial fibrillation: a retrospective cohort study 1. The lactate-to-albumin ratio...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.